Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increasing incidence of the sexually transmitted diseases (STDs)
4.1.2 Increasing government initiatives and private firms to prevent unwanted abortions and pregnancies
4.1.3 High unmet contraceptive needs in developing economies
4.1.4 Increasing population globally
4.1.5 Effective contraception and fewer side effects of IUCDs
4.1.6 Conceivable non-contraception health benefits
4.2 Restraints
4.2.1 Stringent regulations and reimbursement policies
4.2.2 Religious and Cultural Opposition towards contraceptive methods
4.2.3 High cost of the treatment
4.2.4 Constrained access in developing economies
4.2.5 Lack of awareness
4.3 Opportunities
4.3.1 High potential growth from emerging markets
4.4 Challenges
4.4.1 Several concerns pertaining to side effects
4.4.2 Increasing elderly population pool and rise in infertility prevalence
Chapter 5 Asia-Pacific Contraceptive Devices Market– By Type
5.1 Condoms
5.2 Diaphragms
5.3 Cervical caps
5.4 Sponges
5.5 Vaginal rings
5.6 IUD
5.7 Implants
Chapter 6 Asia-Pacific Contraceptive Devices Market– By Gender
6.1 Male
6.2 Female
Chapter 7 Asia-Pacific Contraceptive Devices Market– By End-Users
7.1 Hospitals
7.2 Homecare
7.3 Gynaecology centers
7.4 Clinics
7.5 Ambulatory surgical centers (ASC)
7.6 Others
Chapter 8 Asia-Pacific Contraceptive Devices Market- By Geography
8.1 Introduction
8.2 China
8.3 Japan
8.4 India
8.5 South Korea
8.6 Australia & New Zealand
8.7 Rest of APAC
Chapter 9 Asia-Pacific Contraceptive Devices Market- Company Profiles
9.1 Bayer Healthcare Pharmaceuticals
9.2 Actavis, Inc.
9.3 Cooper Surgical, Inc.
9.4 The Female Health Company
9.5 Merck & Co., Inc.
9.6 Mayer Laboratories, Inc.
9.7 Pfizer, Inc.
9.8 Church & Dwight, Co., Inc.
9.9 Medisafe Distribution Inc.
9.10 Teva Pharmaceutical Industries Limited
9.11 Fuji latex co. ltd
9.12 Johnson & Johnson, Ltd
9.13 Agile Therapeutics
9.14 Ani Pharmaceuticals, Inc
9.15 Reckitt Benckiser Plc
Chapter 10 Asia-Pacific Contraceptive Devices Market- Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
